B Cell Depletion Drugs

Multiple Sclerosis - B Cell Depleting Medications - Q&A

Aaron Boster MD

Does B Cell Depletion Matter?

Risk of B-Cell Depleters Long-Term (Ocrevus, Rituximab, Kesimpta, Briumvi)

Dr. Brandon Beaber

The Role of B Cells in Progressive MS and the Long term Effects of B Cell Depletion

The France Foundation

Blood Tests for B-Cell Drugs (Ocrevus, Rituximab, Kesimpta, Briumvi)

Dr. Brandon Beaber

Dr E Ann Yeh - Longer-term safety of B-cell therapies in MS

At the Limits - Leading Medical Education

5/14/24 - B Cell Depletion and Immunodeficiency (What the Allergist Needs to Know)

UW AI Teaching Series

B-Cell Depletion De-Escalation as an MS Treatment Strategy – Enrique Alavarez, M.D., Ph.D.

Seattle Science Foundation

Anito-Cel, a novel anti-BCMA CAR T-cell, for Relapsed/Refractory Myeloma | Ciara Freeman | #ASH24

HealthTree Foundation for Multiple Myeloma

Prof. Rovin on B-cell depletion in Lupus Nephritis

Rituximab Responses and CD4+ T cell Depletion

Professor Fredrik Piehl - 'Is B-cell depletion sufficient as a treatment strategy in MS?'

At the Limits - Leading Medical Education

New Therapy Targets Autoreactive B Cells in Autoimmunity | Johns Hopkins Rheumatology

Johns Hopkins Rheumatology

Fenebrutinib for Multiple Sclerosis Explained by Neurologist

Dr. Brandon Beaber

Systemic Lupus Erythematosus

ClevelandClinicCME

Ocrevus, Rituxan & Kesimpta: How They Work and When to Use Them

Aaron Boster MD

B-Cell Depletion And Comparison Between These Drugs

MS Treatment De-Escalation

Dr. Brandon Beaber

How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others

B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment Landscape